NARI Insider Trading Activity and SEC Form 4 Filings
NARI insider trading summary
No open-market insider purchases or sales of Inari Medical, Inc. (NARI) have been reported on SEC Form 4 in the past 12 months.
Latest NARI insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jan 6, 2025 | William Hoffman | Director | Sell | $8.5M (141,075 @ $60.13) |
| Jan 6, 2025 | William Hoffman | Director | Sell | $3.6M (58,925 @ $61.27) |
| Dec 20, 2024 | Andrew Hykes | President and CEO | Sell | $132K (2,400 @ $55.20) |
| Dec 20, 2024 | Andrew Hykes | President and CEO | Sell | $33K (600 @ $55.65) |
| Dec 16, 2024 | William Hoffman | Director | Sell | $8K (132 @ $56.89) |
| Dec 16, 2024 | William Hoffman | Director | Sell | $422K (7,467 @ $56.51) |
| Dec 16, 2024 | William Hoffman | Director | Sell | $133K (2,347 @ $56.82) |
| Dec 16, 2024 | William Hoffman | Director | Sell | $114K (2,100 @ $54.42) |
| Dec 16, 2024 | William Hoffman | Director | Sell | $1.2M (20,917 @ $55.23) |
| Dec 16, 2024 | William Hoffman | Director | Sell | $765K (13,560 @ $56.45) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.